
Laura Lynne Stockton
Examiner (ID: 6934, Phone: (571)272-0710 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 2899, 1613, 1201, 1614, 1646, 1626 |
| Total Applications | 3246 |
| Issued Applications | 2197 |
| Pending Applications | 344 |
| Abandoned Applications | 753 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15099719
[patent_doc_number] => 10471154
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-12
[patent_title] => Spirocyclic indolone polyethylene glycol carbonate compound, composition, preparation method and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/324034
[patent_app_country] => US
[patent_app_date] => 2016-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6631
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16324034
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/324034 | Spirocyclic indolone polyethylene glycol carbonate compound, composition, preparation method and use thereof | Aug 7, 2016 | Issued |
Array
(
[id] => 11290413
[patent_doc_number] => 20160340345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-24
[patent_title] => 'SYNTHESIS OF ANTIVIRAL COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 15/228825
[patent_app_country] => US
[patent_app_date] => 2016-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 19241
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15228825
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/228825 | Synthesis of antiviral compound | Aug 3, 2016 | Issued |
Array
(
[id] => 13339609
[patent_doc_number] => 20180221344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-09
[patent_title] => CYCLIC COMPOUNDS USEFUL AS MODULATORS OF TNF ALPHA
[patent_app_type] => utility
[patent_app_number] => 15/749611
[patent_app_country] => US
[patent_app_date] => 2016-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23236
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15749611
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/749611 | Cyclic compounds useful as modulators of TNF a | Aug 1, 2016 | Issued |
Array
(
[id] => 16141313
[patent_doc_number] => 10703717
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-07
[patent_title] => Water-soluble isatin derivative, and manufacturing method and application thereof
[patent_app_type] => utility
[patent_app_number] => 16/089968
[patent_app_country] => US
[patent_app_date] => 2016-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2907
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16089968
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/089968 | Water-soluble isatin derivative, and manufacturing method and application thereof | Jul 27, 2016 | Issued |
Array
(
[id] => 11436012
[patent_doc_number] => 20170037034
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-09
[patent_title] => 'JAK1 Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 15/221649
[patent_app_country] => US
[patent_app_date] => 2016-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11824
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15221649
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/221649 | JAK1 inhibitors | Jul 27, 2016 | Issued |
Array
(
[id] => 13342663
[patent_doc_number] => 20180222871
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-09
[patent_title] => METHOD FOR PREPARING SUBSTITUTED 3-(2-ANILINO-1-CYCLOHEXYL-1H-BENZIMIDAZOL-5-YL)PROPANOIC ACID DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 15/748027
[patent_app_country] => US
[patent_app_date] => 2016-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5528
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15748027
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/748027 | Method for preparing substituted 3-(2-anilino-1-cyclohexyl-1H-benzimidazol-5-yl)propanoic acid derivatives | Jul 24, 2016 | Issued |
Array
(
[id] => 13302957
[patent_doc_number] => 20180203015
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-19
[patent_title] => DYE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 15/743769
[patent_app_country] => US
[patent_app_date] => 2016-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14394
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 531
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15743769
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/743769 | Dye compounds | Jul 17, 2016 | Issued |
Array
(
[id] => 11697095
[patent_doc_number] => 09686991
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-27
[patent_title] => 'Antiparasitic compounds'
[patent_app_type] => utility
[patent_app_number] => 15/211062
[patent_app_country] => US
[patent_app_date] => 2016-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20949
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15211062
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/211062 | Antiparasitic compounds | Jul 14, 2016 | Issued |
Array
(
[id] => 14852045
[patent_doc_number] => 10414734
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-17
[patent_title] => 5-hydroxyalkylbenzimidazoles as mIDH1 inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/744641
[patent_app_country] => US
[patent_app_date] => 2016-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30643
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15744641
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/744641 | 5-hydroxyalkylbenzimidazoles as mIDH1 inhibitors | Jul 11, 2016 | Issued |
Array
(
[id] => 14242743
[patent_doc_number] => 10271552
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-30
[patent_title] => Heterocyclic compounds as pesticides
[patent_app_type] => utility
[patent_app_number] => 15/741758
[patent_app_country] => US
[patent_app_date] => 2016-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29879
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 223
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15741758
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/741758 | Heterocyclic compounds as pesticides | Jul 4, 2016 | Issued |
Array
(
[id] => 12119233
[patent_doc_number] => 20180002820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-04
[patent_title] => 'COMPOSITION AND METHOD FOR INHIBITING CORROSION OF METALS'
[patent_app_type] => utility
[patent_app_number] => 15/198347
[patent_app_country] => US
[patent_app_date] => 2016-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 1740
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15198347
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/198347 | COMPOSITION AND METHOD FOR INHIBITING CORROSION OF METALS | Jun 29, 2016 | Abandoned |
Array
(
[id] => 13209111
[patent_doc_number] => 10118912
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-06
[patent_title] => Process for the preparation of Ledipasvir
[patent_app_type] => utility
[patent_app_number] => 15/196248
[patent_app_country] => US
[patent_app_date] => 2016-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3373
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 252
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15196248
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/196248 | Process for the preparation of Ledipasvir | Jun 28, 2016 | Issued |
Array
(
[id] => 13492973
[patent_doc_number] => 20180298029
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => GLUCOSE UPTAKE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 15/737911
[patent_app_country] => US
[patent_app_date] => 2016-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61482
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 283
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15737911
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/737911 | Glucose uptake inhibitors | Jun 23, 2016 | Issued |
Array
(
[id] => 12790369
[patent_doc_number] => 20180155292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-07
[patent_title] => NOVEL 5-HT2 ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 15/737125
[patent_app_country] => US
[patent_app_date] => 2016-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21651
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -41
[patent_words_short_claim] => 254
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15737125
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/737125 | 5-HT2 antagonists | Jun 21, 2016 | Issued |
Array
(
[id] => 12837118
[patent_doc_number] => 20180170879
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-21
[patent_title] => PYRAZOLE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/736016
[patent_app_country] => US
[patent_app_date] => 2016-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 86242
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15736016
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/736016 | Pyrazole derivative or pharmaceutically acceptable salt thereof | Jun 21, 2016 | Issued |
Array
(
[id] => 15882791
[patent_doc_number] => 10647727
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-12
[patent_title] => Substituted pyrazolo/imidazolo bicyclic compounds as PDE2 inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/579115
[patent_app_country] => US
[patent_app_date] => 2016-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21402
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15579115
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/579115 | Substituted pyrazolo/imidazolo bicyclic compounds as PDE2 inhibitors | Jun 19, 2016 | Issued |
Array
(
[id] => 11092230
[patent_doc_number] => 20160289198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-06
[patent_title] => 'BENDAMUSTINE DERIVATIVES AND METHODS OF USING SAME'
[patent_app_type] => utility
[patent_app_number] => 15/184968
[patent_app_country] => US
[patent_app_date] => 2016-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 19746
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15184968
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/184968 | Bendamustine derivatives and methods of using same | Jun 15, 2016 | Issued |
Array
(
[id] => 17221777
[patent_doc_number] => 11174267
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-16
[patent_title] => Spiroindolinones and therapeutic uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/735873
[patent_app_country] => US
[patent_app_date] => 2016-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 19
[patent_no_of_words] => 14285
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 622
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15735873
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/735873 | Spiroindolinones and therapeutic uses thereof | Jun 12, 2016 | Issued |
Array
(
[id] => 11325071
[patent_doc_number] => 20160355683
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-08
[patent_title] => 'DYES FOR LABELLING MOLECULAR LIGANDS'
[patent_app_type] => utility
[patent_app_number] => 15/179490
[patent_app_country] => US
[patent_app_date] => 2016-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11372
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15179490
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/179490 | Dyes for labelling molecular ligands | Jun 9, 2016 | Issued |
Array
(
[id] => 12790453
[patent_doc_number] => 20180155320
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-07
[patent_title] => 2-OXO-1,2-DIHYDROPYRIDINE-3-CARBOXAMIDE COMPOUNDS AND THEIR USE AS INHIBITORS OF PDK1
[patent_app_type] => utility
[patent_app_number] => 15/735468
[patent_app_country] => US
[patent_app_date] => 2016-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11664
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15735468
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/735468 | 2-oxo-1,2-dihydropyridine-3-carboxamide compounds and their use as inhibitors of PDK1 | Jun 9, 2016 | Issued |